Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Protein processing in endoplasmic reticulum,0.0005003659510648606,5.521794329242488,41.966580163433456,"['DNAJB1', 'HSPH1', 'HSPA5', 'HSPA6', 'HSPA1B', 'HSPA1A', 'PDIA4']",0.06484001539500289,0,0,7
2,Antigen processing and presentation,0.0008882193889726424,10.441241685144124,73.3632106862194,"['HSPA5', 'HSPA6', 'HSPA1B', 'HSPA1A']",0.06484001539500289,0,0,4
3,Complement and coagulation cascades,0.0017061895212723414,14.459141981613891,92.15523651971502,"['SERPINA1', 'C5AR1', 'PLAT']",0.08303455670192061,0,0,3
4,MicroRNAs in cancer,0.0030984454993524917,5.489678630072719,31.71307604310988,"['ST14', 'CDKN1A', 'PIM1', 'HMOX1', 'VEGFA']",0.09393924854141654,0,0,5
5,Ferroptosis,0.0041701924488888546,10.251540413193187,56.176320353169636,"['ACSL1', 'HMOX1', 'FTL']",0.09393924854141654,0,0,3
6,PPAR signaling pathway,0.005718387604313513,9.076083467094703,46.86951583441164,"['CPT1A', 'ACSL1', 'PLTP']",0.09393924854141654,0,0,3
7,Longevity regulating pathway,0.006099178376092752,5.926136363636363,30.22093216658648,"['HSPA6', 'IGF1', 'HSPA1B', 'HSPA1A']",0.09393924854141654,0,0,4
8,MAPK signaling pathway,0.0065690132719612385,3.8583887043189367,19.389914356615545,"['HSPA6', 'HSPB1', 'IGF1', 'HSPA1B', 'HSPA1A', 'VEGFA']",0.09393924854141654,0,0,6
9,HIF-1 signaling pathway,0.006683257510820692,5.764742014742015,28.87069133169126,"['CDKN1A', 'HMOX1', 'IGF1', 'VEGFA']",0.09393924854141654,0,0,4
10,Adipocytokine signaling pathway,0.007077614616134122,8.356889414547606,41.373441434646836,"['CPT1A', 'ACSL1', 'PRKCQ']",0.09393924854141654,0,0,3
11,Legionellosis,0.007077614616134122,8.356889414547606,41.373441434646836,"['HSPA6', 'HSPA1B', 'HSPA1A']",0.09393924854141654,0,0,3
12,Arachidonic acid metabolism,0.010088076789833164,14.992063492063492,68.90953665170296,"['LTC4S', 'ALOX15B']",0.12273826760963683,0,0,2
13,Transcriptional misregulation in cancer,0.015147793684395044,4.480382775119617,18.772357532455068,"['CDKN1A', 'BCL6', 'PLAT', 'IGF1']",0.15395426796675132,0,0,4
14,Taste transduction,0.015579535149661443,11.655555555555555,48.508057022515764,"['CHRM3', 'ASIC2']",0.15395426796675132,0,0,2
15,Inflammatory mediator regulation of TRP channels,0.015817219311652534,6.097882454624028,25.28582149298478,"['PRKCQ', 'IGF1', 'ASIC2']",0.15395426796675132,0,0,3
16,Prostate cancer,0.01993581671820439,5.560023654642223,21.768812167939966,"['CDKN1A', 'PLAT', 'IGF1']",0.17487457430607692,0,0,3
17,Bladder cancer,0.020362107967145944,9.987301587301587,38.891346949963456,"['CDKN1A', 'VEGFA']",0.17487457430607692,0,0,2
18,Neuroactive ligand-receptor interaction,0.028701786791174015,4.797242083758937,17.034027525303944,"['CHRM3', 'C5AR1', 'GABRG3']",0.22663962174666502,0,0,3
19,Fatty acid degradation,0.029494197350593394,8.062393162393162,28.408340039245765,"['CPT1A', 'ACSL1']",0.22663962174666502,0,0,2
20,JAK-STAT signaling pathway,0.032009622435260364,4.5872007816316565,15.787854803834074,"['CDKN1A', 'PIM1', 'IL21R']",0.23050491191880998,0,0,3
21,Toxoplasmosis,0.03315481609791102,4.521187800963082,15.401730478842063,"['HSPA6', 'HSPA1B', 'HSPA1A']",0.23050491191880998,0,0,3
22,Mineral absorption,0.03561620758021,7.226053639846743,24.098559927281897,"['HMOX1', 'FTL']",0.23636210485048456,0,0,2
23,Estrogen signaling pathway,0.03919753617646975,4.21752808988764,13.661169785955497,"['HSPA6', 'HSPA1B', 'HSPA1A']",0.24881914268541663,0,0,3
24,Lipid and atherosclerosis,0.04496350254187441,3.139393939393939,9.738099161044502,"['HSPA5', 'HSPA6', 'HSPA1B', 'HSPA1A']",0.26892625923173663,0,0,4
25,Fluid shear stress and atherosclerosis,0.049944995109198774,3.807770407472587,11.411251925660693,"['HMOX1', 'PLAT', 'VEGFA']",0.26892625923173663,0,0,3
26,FoxO signaling pathway,0.05137983417507328,3.7620385232744784,11.167647151110941,"['CDKN1A', 'BCL6', 'IGF1']",0.26892625923173663,0,0,3
27,Measles,0.05137983417507328,3.7620385232744784,11.167647151110941,"['HSPA6', 'HSPA1B', 'HSPA1A']",0.26892625923173663,0,0,3
28,Thyroid hormone synthesis,0.051574899030744005,5.816666666666666,17.244789033876266,"['HSPA5', 'PDIA4']",0.26892625923173663,0,0,2
29,Melanoma,0.054030182565142144,5.658858858858859,16.513752387012012,"['CDKN1A', 'IGF1']",0.2720140225693363,0,0,2
30,VEGF signaling pathway,0.0590620667581062,5.367521367521367,15.185611152943862,"['HSPB1', 'VEGFA']",0.2781632821510808,0,0,2
31,IL-17 signaling pathway,0.0590620667581062,5.367521367521367,15.185611152943862,"['S100A9', 'S100A8']",0.2781632821510808,0,0,2
32,p53 signaling pathway,0.06689850153792681,4.982539682539683,13.475670750291027,"['CDKN1A', 'IGF1']",0.30522441326679106,0,0,2
33,PI3K-Akt signaling pathway,0.07603843822880585,2.6085858585858586,6.721063985597417,"['CDKN1A', 'SPP1', 'IGF1', 'VEGFA']",0.3364124842850198,0,0,4
34,Focal adhesion,0.08591651885818521,3.002889245585875,7.370228799543766,"['SPP1', 'IGF1', 'VEGFA']",0.3689356398027953,0,0,3
35,Fatty acid biosynthesis,0.09229644421528713,11.538461538461538,27.493265335694012,['ACSL1'],0.3741541249208616,0,0,1
36,Spliceosome,0.09338477055032493,2.8914544892279146,6.855716672624409,"['HSPA6', 'HSPA1B', 'HSPA1A']",0.3741541249208616,0,0,3
37,Glioma,0.10124114100330459,3.8703703703703702,8.86411602361515,"['CDKN1A', 'IGF1']",0.3741541249208616,0,0,2
38,Renal cell carcinoma,0.10124114100330459,3.8703703703703702,8.86411602361515,"['CDKN1A', 'VEGFA']",0.3741541249208616,0,0,2
39,AGE-RAGE signaling pathway in diabetic complications,0.10428989468667126,3.7995959595959596,8.589293706931784,"['PIM1', 'VEGFA']",0.3741541249208616,0,0,2
40,Pancreatic cancer,0.10428989468667126,3.7995959595959596,8.589293706931784,"['CDKN1A', 'VEGFA']",0.3741541249208616,0,0,2
41,Proteoglycans in cancer,0.10507067891613237,2.738837322911578,6.170934688960116,"['CDKN1A', 'IGF1', 'VEGFA']",0.3741541249208616,0,0,3
42,Pathways in cancer,0.12295490623027835,1.970964144793275,4.131017872812948,"['CDKN1A', 'PIM1', 'HMOX1', 'IGF1', 'VEGFA']",0.4023361287149176,0,0,5
43,Cytokine-cytokine receptor interaction,0.12308204659408288,3.42367941712204,7.172280049744635,"['CX3CR1', 'IL21R']",0.4023361287149176,0,0,2
44,Breast cancer,0.12629060171264075,3.368100358422939,6.969171089665047,"['CDKN1A', 'IGF1']",0.4023361287149176,0,0,2
45,Porphyrin and chlorophyll metabolism,0.1268090682232695,7.984784446322908,16.489160563765445,['HMOX1'],0.4023361287149176,0,0,1
46,Th17 cell differentiation,0.1295191647232954,3.3142857142857145,6.774156130385271,"['IL21R', 'PRKCQ']",0.4023361287149176,0,0,2
47,ErbB signaling pathway,0.1295191647232954,3.3142857142857145,6.774156130385271,"['CDKN1A', 'NRG1']",0.4023361287149176,0,0,2
48,Prion disease,0.13371556092675657,2.104318181818182,4.233973227332321,"['HSPA5', 'HSPA6', 'HSPA1B', 'HSPA1A']",0.4067181644855512,0,0,4
49,Galactose metabolism,0.1435753769210432,6.918681318681319,13.428434718181322,['MGAM'],0.41720330597257577,0,0,1
50,Ovarian steroidogenesis,0.1435753769210432,6.918681318681319,13.428434718181322,['IGF1'],0.41720330597257577,0,0,1
51,ECM-receptor interaction,0.15183871717856068,6.485576923076923,12.224899969730192,['SPP1'],0.41720330597257577,0,0,1
52,Nicotinate and nicotinamide metabolism,0.15183871717856068,6.485576923076923,12.224899969730192,['NAMPT'],0.41720330597257577,0,0,1
53,Cholinergic synapse,0.15262425351055942,2.9806349206349205,5.60292669667173,"['CHRM3', 'KCNQ5']",0.41720330597257577,0,0,2
54,Insulin resistance,0.15598959145229283,2.938341158059468,5.459337954612335,"['CPT1A', 'PRKCQ']",0.41720330597257577,0,0,2
55,Starch and sucrose metabolism,0.1600231858524948,6.103425985778927,11.184140933884693,['MGAM'],0.41720330597257577,0,0,1
56,Viral protein interaction with cytokine and cytokine receptor,0.1600231858524948,6.103425985778927,11.184140933884693,['CX3CR1'],0.41720330597257577,0,0,1
57,ABC transporters,0.16812952753054525,5.763736263736264,10.27686048797485,['ABCC3'],0.4232226037837863,0,0,1
58,Basal cell carcinoma,0.16812952753054525,5.763736263736264,10.27686048797485,['CDKN1A'],0.4232226037837863,0,0,1
59,Nicotine addiction,0.184110773563961,5.1862637362637365,8.776287147619403,['GABRG3'],0.45559615153115773,0,0,1
60,Aldosterone-regulated sodium reabsorption,0.19978827415671827,4.713786213786213,7.5915390386084205,['IGF1'],0.45817200786437823,0,0,1
61,Thyroid cancer,0.19978827415671827,4.713786213786213,7.5915390386084205,['CDKN1A'],0.45817200786437823,0,0,1
62,Carbohydrate digestion and absorption,0.19978827415671827,4.713786213786213,7.5915390386084205,['MGAM'],0.45817200786437823,0,0,1
63,Protein export,0.19978827415671827,4.713786213786213,7.5915390386084205,['HSPA5'],0.45817200786437823,0,0,1
64,Apelin signaling pathway,0.20084252399534389,2.4801587301587302,3.9812354680061914,"['SPP1', 'PLAT']",0.45817200786437823,0,0,2
65,AMPK signaling pathway,0.20435929414513554,2.450718954248366,3.8914368017328633,"['CPT1A', 'IGF1']",0.4590224145413814,0,0,2
66,Arginine and proline metabolism,0.2227474654076197,4.146813186813187,6.2273381638140535,['AZIN2'],0.4831628317737851,0,0,1
67,Cholesterol metabolism,0.2227474654076197,4.146813186813187,6.2273381638140535,['PLTP'],0.4831628317737851,0,0,1
68,Human papillomavirus infection,0.22503474356587252,1.8755298391980084,2.7973536420086664,"['CDKN1A', 'SPP1', 'VEGFA']",0.4831628317737851,0,0,3
69,Circadian rhythm,0.23025477568502298,3.9868977176669484,5.855033847169755,['PER3'],0.4872057572465704,0,0,1
70,Staphylococcus aureus infection,0.24505488152410929,3.7013343799058083,5.205086925567927,['C5AR1'],0.5039156718664782,0,0,1
71,Bile secretion,0.24505488152410929,3.7013343799058083,5.205086925567927,['ABCC3'],0.5039156718664782,0,0,1
72,Hepatocellular carcinoma,0.2505615877844194,2.122675736961451,2.937890477182174,"['CDKN1A', 'HMOX1']",0.5080832196739615,0,0,2
73,Inflammatory bowel disease,0.25957345557386874,3.453846153846154,4.65825601719838,['IL21R'],0.5191469111477375,0,0,1
74,Chemical carcinogenesis,0.2684562766350094,2.018554476806904,2.6545348269907207,"['BCL6', 'VEGFA']",0.5295644422986985,0,0,2
75,Calcium signaling pathway,0.2720365285780985,1.998931623931624,2.602247018734807,"['CHRM3', 'VEGFA']",0.5295644422986985,0,0,2
76,GnRH secretion,0.3014924715834147,2.8763736263736264,3.448801411951103,['SPP1'],0.5746872860653488,0,0,1
77,Endocytosis,0.3030885001851497,1.5847829806650318,1.891803678951348,"['HSPA6', 'HSPA1B', 'HSPA1A']",0.5746872860653488,0,0,3
78,Endometrial cancer,0.32812535149535976,2.5876373626373628,2.8835584701634107,['CDKN1A'],0.5748983282690269,0,0,1
79,Rap1 signaling pathway,0.3290688390808743,1.7294444444444443,1.9222572875953068,"['IGF1', 'VEGFA']",0.5748983282690269,0,0,2
80,Amoebiasis,0.33462507463430197,2.524256231573305,2.7634157626754723,['HSPB1'],0.5748983282690269,0,0,1
81,Vibrio cholerae infection,0.33462507463430197,2.524256231573305,2.7634157626754723,['PDIA4'],0.5748983282690269,0,0,1
82,Hypertrophic cardiomyopathy,0.3410625961757157,2.463893249607535,2.6503834867944454,['IGF1'],0.5748983282690269,0,0,1
83,Salivary secretion,0.34743850491236783,2.4063378481983135,2.5439023931342835,['CHRM3'],0.5748983282690269,0,0,1
84,Gastric acid secretion,0.34743850491236783,2.4063378481983135,2.5439023931342835,['CHRM3'],0.5748983282690269,0,0,1
85,Ras signaling pathway,0.35369691662891684,1.6328958880139983,1.6970930270257425,"['IGF1', 'VEGFA']",0.5748983282690269,0,0,2
86,Acute myeloid leukemia,0.35375338414055857,2.3513986013986012,2.44346823345415,['PIM1'],0.5748983282690269,0,0,1
87,Small cell lung cancer,0.35375338414055857,2.3513986013986012,2.44346823345415,['CDKN1A'],0.5748983282690269,0,0,1
88,Dilated cardiomyopathy,0.35375338414055857,2.3513986013986012,2.44346823345415,['IGF1'],0.5748983282690269,0,0,1
89,Long-term depression,0.35375338414055857,2.3513986013986012,2.44346823345415,['IGF1'],0.5748983282690269,0,0,1
90,Kaposi sarcoma-associated herpesvirus infection,0.3571915019064288,1.6199652777777778,1.6677270722664075,"['CDKN1A', 'VEGFA']",0.5748983282690269,0,0,2
91,Rheumatoid arthritis,0.3600078116218766,2.2989010989010987,2.348625292446943,['VEGFA'],0.5748983282690269,0,0,1
92,Pancreatic secretion,0.3662023597878048,2.2486860965121833,2.258960799267011,['CHRM3'],0.5748983282690269,0,0,1
93,Peroxisome,0.3662023597878048,2.2486860965121833,2.258960799267011,['ACSL1'],0.5748983282690269,0,0,1
94,Insulin secretion,0.372337595629218,2.2006079027355625,2.17410008659748,['CHRM3'],0.5783115847007002,0,0,1
95,Human cytomegalovirus infection,0.3917457741058437,1.5009661835748793,1.4066187289255445,"['CDKN1A', 'VEGFA']",0.6020514002047703,0,0,2
96,Th1 and Th2 cell differentiation,0.40214356778814137,1.9879543533389687,1.8109193055451336,['PRKCQ'],0.6052882566708107,0,0,1
97,Non-small cell lung cancer,0.40214356778814137,1.9879543533389687,1.8109193055451336,['CDKN1A'],0.6052882566708107,0,0,1
98,Serotonergic synapse,0.407934543703825,1.9502384408044786,1.7486784692182344,['ALOX15B'],0.6077392181710046,0,0,1
99,B cell receptor signaling pathway,0.4136700306125553,1.913919413919414,1.6893911167191094,['LILRB3'],0.6100588330245765,0,0,1
100,GABAergic synapse,0.4305487917492597,1.8126084441873915,1.5274753915872932,['GABRG3'],0.6101839261381719,0,0,1
101,Chronic myeloid leukemia,0.4360675326189942,1.7811671087533156,1.4782941696423153,['CDKN1A'],0.6101839261381719,0,0,1
102,NF-kappa B signaling pathway,0.4360675326189942,1.7811671087533156,1.4782941696423153,['PRKCQ'],0.6101839261381719,0,0,1
103,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.4360675326189942,1.7811671087533156,1.4782941696423153,['PRKCQ'],0.6101839261381719,0,0,1
104,Progesterone-mediated oocyte maturation,0.4360675326189942,1.7811671087533156,1.4782941696423153,['IGF1'],0.6101839261381719,0,0,1
105,Toll-like receptor signaling pathway,0.45230830750558604,1.6930282831922177,1.34323380120377,['SPP1'],0.6101839261381719,0,0,1
106,Colorectal cancer,0.45230830750558604,1.6930282831922177,1.34323380120377,['CDKN1A'],0.6101839261381719,0,0,1
107,Gastric cancer,0.46287757623726217,1.6389324960753533,1.2624576949628954,['CDKN1A'],0.6101839261381719,0,0,1
108,Morphine addiction,0.46287757623726217,1.6389324960753533,1.2624576949628954,['GABRG3'],0.6101839261381719,0,0,1
109,"Parathyroid hormone synthesis, secretion and action",0.46287757623726217,1.6389324960753533,1.2624576949628954,['CDKN1A'],0.6101839261381719,0,0,1
110,T cell receptor signaling pathway,0.46808629950325514,1.6131524725274726,1.2245482351503052,['PRKCQ'],0.6101839261381719,0,0,1
111,Circadian entrainment,0.46808629950325514,1.6131524725274726,1.2245482351503052,['PER3'],0.6101839261381719,0,0,1
112,Glucagon signaling pathway,0.46808629950325514,1.6131524725274726,1.2245482351503052,['CPT1A'],0.6101839261381719,0,0,1
113,Signaling pathways regulating pluripotency of stem cells,0.4732450549826,1.5881656804733728,1.188173350065204,['IGF1'],0.6114493630748637,0,0,1
114,Vascular smooth muscle contraction,0.47835431683784135,1.563936063936064,1.1532520406533364,['PRKCQ'],0.6126292127923231,0,0,1
115,Thermogenesis,0.4898916810482924,1.228968253968254,0.8769560708035735,"['CPT1A', 'ACSL1']",0.6219494385482669,0,0,2
116,Cushing syndrome,0.4983057556154677,1.4739403453689168,1.026660505961892,['CDKN1A'],0.6271779337918817,0,0,1
117,Cell cycle,0.5031745069412618,1.4530258473920445,0.9979646504735232,['CDKN1A'],0.6278929744737113,0,0,1
118,"Growth hormone synthesis, secretion and action",0.5127722308490147,1.4129158512720157,0.9437197385273387,['IGF1'],0.6291155101172786,0,0,1
119,Relaxin signaling pathway,0.5127722308490147,1.4129158512720157,0.9437197385273387,['VEGFA'],0.6291155101172786,0,0,1
120,Oocyte meiosis,0.5175020868724117,1.3936738936738937,0.9180711395758184,['IGF1'],0.6296275390281009,0,0,1
121,Neutrophil extracellular trap formation,0.5359715870409765,1.3216398985629756,0.8242726120173399,['C5AR1'],0.6467095182477898,0,0,1
122,Thyroid hormone signaling pathway,0.5580777410242093,1.2413610485899642,0.724032527911599,['MED12L'],0.6678635261437258,0,0,1
123,Osteoclast differentiation,0.5750098932277714,1.1837817355058735,0.6550669701459074,['LILRB3'],0.682532068384184,0,0,1
124,Necroptosis,0.5832337038951395,1.1569329546857636,0.6237804274573284,['FTL'],0.6859504937373143,0,0,1
125,Hepatitis C,0.5872863816244129,1.1439560439560439,0.6088622590419063,['CDKN1A'],0.6859504937373143,0,0,1
126,Insulin signaling pathway,0.6069723684325411,1.0831694621168306,0.5407961950488825,['SH2B2'],0.6977792581980393,0,0,1
127,Neurotrophin signaling pathway,0.6069723684325411,1.0831694621168306,0.5407961950488825,['SH2B2'],0.6977792581980393,0,0,1
128,Chemokine signaling pathway,0.6329813495072785,1.0080801551389786,0.461009491585967,['CX3CR1'],0.7012357189696578,0,0,1
129,Cellular senescence,0.6365551848127263,0.9981862797396778,0.45086493561005986,['CDKN1A'],0.7012357189696578,0,0,1
130,Retrograde endocannabinoid signaling,0.6365551848127263,0.9981862797396778,0.45086493561005986,['GABRG3'],0.7012357189696578,0,0,1
131,mTOR signaling pathway,0.6400945944838831,0.9884826711749789,0.44100097653804077,['IGF1'],0.7012357189696578,0,0,1
132,Influenza A,0.6435999064516037,0.9789638932496075,0.4314078595712734,['DNAJB1'],0.7012357189696578,0,0,1
133,NOD-like receptor signaling pathway,0.6435999064516037,0.9789638932496075,0.4314078595712734,['NAMPT'],0.7012357189696578,0,0,1
134,Oxytocin signaling pathway,0.6435999064516037,0.9789638932496075,0.4314078595712734,['CDKN1A'],0.7012357189696578,0,0,1
135,Hepatitis B,0.6539144901060752,0.9514652014652014,0.40416213724115513,['CDKN1A'],0.7071964115221258,0,0,1
136,Autophagy,0.6736659315774552,0.9008097165991903,0.35583870229461534,['PRKCQ'],0.7232001912522681,0,0,1
137,Viral carcinogenesis,0.7041366480411939,0.8272775611485289,0.29019477181225034,['CDKN1A'],0.7503938001022943,0,0,1
138,Regulation of actin cytoskeleton,0.7264721767946742,0.7764735264735265,0.2481260709765685,['CHRM3'],0.7685865058842206,0,0,1
139,Epstein-Barr virus infection,0.7317902572593118,0.7647203542725931,0.2387926024573163,['CDKN1A'],0.7686430040277663,0,0,1
140,Amyotrophic lateral sclerosis,0.738663260428957,0.762106135986733,0.23085195590234056,"['HSPA5', 'NRG1']",0.7703202573044838,0,0,2
141,Human T-cell leukemia virus 1 infection,0.7708112346985827,0.6819780219780219,0.17752690407475857,['CDKN1A'],0.7981449664254827,0,0,1
142,Coronavirus disease,0.7860641415148778,0.6510814026737594,0.1567262870690406,['C5AR1'],0.8082067933885363,0,0,1
143,Pathways of neurodegeneration,0.8259218882166198,0.6285517715858273,0.12021371700583103,"['CHRM3', 'HSPA5']",0.8392560122279511,0,0,2
144,Shigellosis,0.8277593545261984,0.5697096199889496,0.1076938054906363,['PRKCQ'],0.8392560122279511,0,0,1
145,Parkinson disease,0.854376026153181,0.5193429019959632,0.08173619600557151,['HSPA5'],0.8602682746094098,0,0,1
146,Alzheimer disease,0.918869882397193,0.39663865546218485,0.03355989519871589,['CHRM3'],0.918869882397193,0,0,1
